SNPs in the DNase 1 Gene Impair Its Activity and Are Increased in a STE-ACS Patient Cohort Compared to Healthy Controls
Single Nucleotide Polymorphisms in the Deoxyribonuclease 1 Gene Impair Its Activity and Are Increased in a ST-elevation Acute Coronary Syndrome Patient Cohort Compared to Healthy Controls
1 other identifier
observational
800
0 countries
N/A
Brief Summary
Neutrophil extracellular traps (NETs) and deoxyribonuclease (DNase) activity determine outcome in ST elevation acute coronary syndrome (STE-ACS). DNase single nucleotide polymorphisms (SNPs) were increased in a japanese cohort. In the present study, the investigators seek to measure DNase SNPs frequency in a caucasian STE-ACS cohort compared to healthy controls (each n=400). The investigators will compute polymorphisms, DNase activity, NET surrogate markers and clinical variables in regression models.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2015
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2015
CompletedFirst Submitted
Initial submission to the registry
November 12, 2015
CompletedFirst Posted
Study publicly available on registry
November 25, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2019
CompletedMarch 23, 2017
March 1, 2017
3.3 years
November 12, 2015
March 21, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Frequency of SNPs of the DNase 1 and DNase gamma genes in the STE-ACS patient population compared to healthy controls
through study completion, an average of 2 years
Secondary Outcomes (7)
Correlation of SNPs of the DNase 1 and gamma gene with DNase activity
through study completion, an average of 2 years
Correlation of SNPs with major adverse cardiac events
through study completion, an average of 2 years
Correlation of DNAse activity with major adverse cardiac events
through study completion, an average of 2 years
Correlation of SNPs with DNA-Histone complex levels
through study completion, an average of 2 years
Correlation of SNPs with MPO-DNA complex levels
through study completion, an average of 2 years
- +2 more secondary outcomes
Study Arms (2)
ST elevation myocardial infarction patient cohort
Patients who suffered from ST elevation myocardial infarction since 2006, referred to the General Hospital of Vienna and received primary percutaneous coronary intervention.
Healthy proband cohort
Age matched healthy individuals who voluntarily participate in the study.
Interventions
Eligibility Criteria
ST elevation myocardial infarction patients, who have been hospitalized in the General Hospital of Vienna since 2006 for ST-elevation acute coronary syndrome undergoing primary percutaneous coronary intervention (pPCI) with TIMI 0-1.
You may qualify if:
- Medical history
- Detailed clinical examination
- Electrocardiography
- Echocardiography
- Routine blood draw (differential blood count, clotting factors including fibrinogen, liver enzymes, creatine kinase (CK), CK-MB, C-reactive protein (CRP), N-terminal pro-brain natriuretic peptide (NT-proBNP), HbA1c
- Blood draw for research experiments
You may not qualify if:
- Patients under 18 years; auto-immune disease, immune-modulating medication, systemic infection
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (10)
Nichols M, Townsend N, Scarborough P, Rayner M. Trends in age-specific coronary heart disease mortality in the European Union over three decades: 1980-2009. Eur Heart J. 2013 Oct;34(39):3017-27. doi: 10.1093/eurheartj/eht159. Epub 2013 Jun 25.
PMID: 23801825BACKGROUNDHansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005 Apr 21;352(16):1685-95. doi: 10.1056/NEJMra043430. No abstract available.
PMID: 15843671BACKGROUNDMangold A, Alias S, Scherz T, Hofbauer M, Jakowitsch J, Panzenbock A, Simon D, Laimer D, Bangert C, Kammerlander A, Mascherbauer J, Winter MP, Distelmaier K, Adlbrecht C, Preissner KT, Lang IM. Coronary neutrophil extracellular trap burden and deoxyribonuclease activity in ST-elevation acute coronary syndrome are predictors of ST-segment resolution and infarct size. Circ Res. 2015 Mar 27;116(7):1182-92. doi: 10.1161/CIRCRESAHA.116.304944. Epub 2014 Dec 29.
PMID: 25547404BACKGROUNDFuchs TA, Brill A, Duerschmied D, Schatzberg D, Monestier M, Myers DD Jr, Wrobleski SK, Wakefield TW, Hartwig JH, Wagner DD. Extracellular DNA traps promote thrombosis. Proc Natl Acad Sci U S A. 2010 Sep 7;107(36):15880-5. doi: 10.1073/pnas.1005743107. Epub 2010 Aug 23.
PMID: 20798043BACKGROUNDBorissoff JI, Joosen IA, Versteylen MO, Brill A, Fuchs TA, Savchenko AS, Gallant M, Martinod K, Ten Cate H, Hofstra L, Crijns HJ, Wagner DD, Kietselaer BLJH. Elevated levels of circulating DNA and chromatin are independently associated with severe coronary atherosclerosis and a prothrombotic state. Arterioscler Thromb Vasc Biol. 2013 Aug;33(8):2032-2040. doi: 10.1161/ATVBAHA.113.301627. Epub 2013 Jul 1.
PMID: 23818485BACKGROUNDNapirei M, Ludwig S, Mezrhab J, Klockl T, Mannherz HG. Murine serum nucleases--contrasting effects of plasmin and heparin on the activities of DNase1 and DNase1-like 3 (DNase1l3). FEBS J. 2009 Feb;276(4):1059-73. doi: 10.1111/j.1742-4658.2008.06849.x. Epub 2009 Jan 16.
PMID: 19154352BACKGROUNDUeki M, Takeshita H, Fujihara J, Iida R, Yuasa I, Kato H, Panduro A, Nakajima T, Kominato Y, Yasuda T. Caucasian-specific allele in non-synonymous single nucleotide polymorphisms of the gene encoding deoxyribonuclease I-like 3, potentially relevant to autoimmunity, produces an inactive enzyme. Clin Chim Acta. 2009 Sep;407(1-2):20-4. doi: 10.1016/j.cca.2009.06.022. Epub 2009 Jun 24.
PMID: 19559017BACKGROUNDUeki M, Kimura-Kataoka K, Takeshita H, Fujihara J, Iida R, Sano R, Nakajima T, Kominato Y, Kawai Y, Yasuda T. Evaluation of all non-synonymous single nucleotide polymorphisms (SNPs) in the genes encoding human deoxyribonuclease I and I-like 3 as a functional SNP potentially implicated in autoimmunity. FEBS J. 2014 Jan;281(1):376-90. doi: 10.1111/febs.12608. Epub 2013 Dec 10.
PMID: 24206041BACKGROUNDKumamoto T, Kawai Y, Arakawa K, Morikawa N, Kuribara J, Tada H, Taniguchi K, Tatami R, Miyamori I, Kominato Y, Kishi K, Yasuda T. Association of Gln222Arg polymorphism in the deoxyribonuclease I (DNase I) gene with myocardial infarction in Japanese patients. Eur Heart J. 2006 Sep;27(17):2081-7. doi: 10.1093/eurheartj/ehl177. Epub 2006 Jul 28.
PMID: 16877481BACKGROUNDCrimi G, Pica S, Raineri C, Bramucci E, De Ferrari GM, Klersy C, Ferlini M, Marinoni B, Repetto A, Romeo M, Rosti V, Massa M, Raisaro A, Leonardi S, Rubartelli P, Oltrona Visconti L, Ferrario M. Remote ischemic post-conditioning of the lower limb during primary percutaneous coronary intervention safely reduces enzymatic infarct size in anterior myocardial infarction: a randomized controlled trial. JACC Cardiovasc Interv. 2013 Oct;6(10):1055-63. doi: 10.1016/j.jcin.2013.05.011.
PMID: 24156966BACKGROUND
Biospecimen
Whole blood draw, DNA isolation, plasma isolation
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
November 12, 2015
First Posted
November 25, 2015
Study Start
September 1, 2015
Primary Completion
December 1, 2018
Study Completion
December 1, 2019
Last Updated
March 23, 2017
Record last verified: 2017-03